Tokyo Tape
Sign in
← Koa Shoji Holdings

Half-year report · Q2

9273.TEDINET S100V85J
Period2024-07-01 → 2024-12-31
Filed2025-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥12.3bn2024-07-01 → 2024-12-31Cons.Net sales
Revenue¥22.1bn2023-07-01 → 2024-06-30Cons.Net sales (5-year summary)
Revenue¥11.4bn2023-07-01 → 2023-12-31Cons.Net sales
Operating income¥3.1bn2024-07-01 → 2024-12-31Cons.Operating income
Operating income¥2.4bn2023-07-01 → 2023-12-31Cons.Operating income
Ordinary income¥3.1bn2024-07-01 → 2024-12-31Cons.Ordinary income
Ordinary income¥4.4bn2023-07-01 → 2024-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.4bn2023-07-01 → 2023-12-31Cons.Ordinary income
Profit before tax¥3.1bn2024-07-01 → 2024-12-31Cons.Income before income taxes
Profit before tax¥2.4bn2023-07-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)¥2.0bn2024-07-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.9bn2023-07-01 → 2024-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.6bn2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income¥2.0bn2024-07-01 → 2024-12-31Cons.Profit loss
Net income¥1.6bn2023-07-01 → 2023-12-31Cons.Profit loss
Total assets¥33.6bnat 2024-12-31Cons.Assets
Total assets¥32.0bnat 2024-06-30Cons.Assets
Total assets¥29.6bnat 2023-12-31Cons.Total assets (5-year summary)
Total liabilities¥7.0bnat 2024-12-31Cons.Liabilities
Total liabilities¥7.0bnat 2024-06-30Cons.Liabilities
Net assets / equity¥26.6bnat 2024-12-31Cons.Net assets
Net assets / equity¥25.1bnat 2024-06-30Cons.Net assets
Net assets / equity¥22.0bnat 2023-12-31Cons.Net assets (5-year summary)
Cash and deposits¥12.5bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥14.0bnat 2024-06-30Cons.Cash and deposits
Cash & equivalents¥9.8bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥13.2bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥10.3bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥10.0bnat 2023-06-30dCons.Cash and cash equivalents
Operating cash flow¥1.0bn2024-07-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥3.8bn2023-07-01 → 2024-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.5bn2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥3.7bn2024-07-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.5bn2023-07-01 → 2024-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥644m2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥738m2024-07-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥795m2023-07-01 → 2024-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥639m2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥48.662024-07-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥74.142023-07-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥39.462023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio79.1%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.3%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio74.2%at 2023-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-07-01 → 2024-12-31−¥604m
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2024-12-31−¥604m
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2024-12-31¥81m
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue2024-07-01 → 2024-12-31¥8.0bn
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue external2024-07-01 → 2024-12-31¥7.4bn
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥604m
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentsegment profit2024-07-01 → 2024-12-31¥1.6bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue2024-07-01 → 2024-12-31¥4.9bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue external2024-07-01 → 2024-12-31¥4.9bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentsegment profit2024-07-01 → 2024-12-31¥1.4bn
—segment totalrevenue2024-07-01 → 2024-12-31¥12.9bn
—segment totalrevenue external2024-07-01 → 2024-12-31¥12.3bn
—segment totalrevenue intersegment2024-07-01 → 2024-12-31¥604m
—segment totalsegment profit2024-07-01 → 2024-12-31¥3.0bn
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥871m
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥871m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥38m
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue2023-07-01 → 2023-12-31¥7.9bn
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue external2023-07-01 → 2023-12-31¥7.0bn
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥871m
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentsegment profit2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue2023-07-01 → 2023-12-31¥4.4bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue external2023-07-01 → 2023-12-31¥4.4bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentsegment profit2023-07-01 → 2023-12-31¥1.0bn
—segment totalrevenue2023-07-01 → 2023-12-31¥12.3bn
—segment totalrevenue external2023-07-01 → 2023-12-31¥11.4bn
—segment totalrevenue intersegment2023-07-01 → 2023-12-31¥871m
—segment totalsegment profit2023-07-01 → 2023-12-31¥2.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 494
ItemContextValueUnit
Gross profitPrior1YTDDuration3458609000JPY
Gross profitCurrentYTDDuration4157331000JPY
Selling general and administrative expensesPrior1YTDDuration1065308000JPY
Selling general and administrative expensesCurrentYTDDuration1093853000JPY
Operating incomePrior1YTDDuration2393300000JPY
Operating incomeCurrentYTDDuration3063478000JPY
Interest and dividends income noiPrior1YTDDuration1948000JPY
Interest and dividends income noiCurrentYTDDuration2210000JPY
Foreign exchange gains noiPrior1YTDDuration12844000JPY
Foreign exchange gains noiCurrentYTDDuration－JPY
Commission fee noiPrior1YTDDuration3942000JPY
Commission fee noiCurrentYTDDuration150000JPY
Compensation income noiPrior1YTDDuration640000JPY
Compensation income noiCurrentYTDDuration33892000JPY
Insurance income noiPrior1YTDDuration26533000JPY
Insurance income noiCurrentYTDDuration－JPY
Other noiPrior1YTDDuration4269000JPY
Other noiCurrentYTDDuration4094000JPY
Non operating incomePrior1YTDDuration50177000JPY
Non operating incomeCurrentYTDDuration40346000JPY
Interest expenses noePrior1YTDDuration3359000JPY
Interest expenses noeCurrentYTDDuration6349000JPY
Foreign exchange losses noePrior1YTDDuration－JPY
Foreign exchange losses noeCurrentYTDDuration21886000JPY
Other noePrior1YTDDuration9000JPY
Other noeCurrentYTDDuration9970000JPY
Non operating expensesPrior1YTDDuration3368000JPY
Non operating expensesCurrentYTDDuration38206000JPY
Ordinary incomePrior1YTDDuration2440109000JPY
Ordinary incomeCurrentYTDDuration3065617000JPY
Income before income taxesPrior1YTDDuration2440109000JPY
Income before income taxesCurrentYTDDuration3065617000JPY
Income taxes currentPrior1YTDDuration869987000JPY
Income taxes currentCurrentYTDDuration978314000JPY
Income taxes deferredPrior1YTDDuration6816000JPY
Income taxes deferredCurrentYTDDuration37974000JPY
Income taxesPrior1YTDDuration876803000JPY
Income taxesCurrentYTDDuration1016288000JPY
Profit lossPrior1YTDDuration1563306000JPY
Profit lossCurrentYTDDuration2049328000JPY
Profit loss attributable to owners of parentPrior1YTDDuration1563306000JPY
Profit loss attributable to owners of parentCurrentYTDDuration2049328000JPY
Profit lossPrior1YTDDuration1563306000JPY
Profit lossCurrentYTDDuration2049328000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration15175000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-573000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration-40951000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration5120000JPY
Other comprehensive incomePrior1YTDDuration-25775000JPY
Other comprehensive incomeCurrentYTDDuration4547000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-06-30pass rounding
balance sheet identityconsolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-07-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass